Top 16 Pharmaceutical Companies in India 2024 | IMARC Group

Pharmaceuticals refer to medicinal drugs manufactured or processed for use in medical diagnosis, treatment, or prevention of disease. These products are created through a meticulous process involving drug discovery, development, and rigorous regulatory approval before reaching the market. Branded pharmaceuticals are patented products originating from research companies, generics are cost-effective copies of branded drugs without patent protection, and biologics are complex drugs derived from living organisms. The importance of pharmaceuticals lies in their capacity to improve health outcomes, extend life expectancy, and enhance the quality of life by treating and preventing illnesses. The benefits of pharmaceuticals are vast, ranging from managing chronic conditions like diabetes to combating acute infections through antibiotics and advancing public health through vaccines.

Request to Get the Sample Report: https://www.imarcgroup.com/india-pharmaceutical-market/requestsample

The India pharmaceutical market size reached US$ 54.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 163.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032.

List of Top Companies Operating in the India Pharmaceutical Industry:

• Abbott India Limited (Abbott Laboratories)
• Aurobindo Pharma Limited
• Biocon Limited
• Cadila Pharmaceuticals Limited (CPL)
• Cipla Limited, Divi's Laboratories Limited
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline Pharmaceuticals Limited (GSK plc)
• Lupin Limited, Mankind Pharma Ltd.
• E. Merck India Private Limited
• Novartis India Limited (Novartis AG)
• Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.)
• Procter & Gamble Health Limited (The Procter & Gamble Company)
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd. (Torrent Group)

Explore Complete Blog by IMARC Group: https://www.imarcgroup.com/indian-pharmaceutical-companies

The top Indian pharmaceutical companies are primarily focusing on actively engaging in a range of strategic activities to bolster their positions and capitalize on both domestic and international opportunities. Companies like Sun Pharmaceuticals, Dr. Reddy's Laboratories, Cipla, and Lupin are at the forefront of innovation, investing heavily in research and development (R&D) to expand their portfolios with generic as well as specialty drugs. These firms are also enhancing their manufacturing capabilities to meet the stringent quality standards required in global markets, particularly in the US and Europe.

Furthermore, companies are increasingly venturing into biologics and biosimilars, which represent a significant growth area due to their potential to treat complex diseases like cancer and autoimmune disorders are expanding the market forward. In line with this, strategic collaborations and acquisitions are another strategic focus, allowing these companies to access new technologies, markets, and expertise. For example, partnerships with global pharma companies are being leveraged to facilitate technology transfer and scale up production capabilities.

The government's push towards 'Make in India' has encouraged substantial investment in local manufacturing, reducing dependency on imports, particularly from China. Indian pharmaceutical firms are also focusing on sustainability and ethical practices, improving their compliance with global environmental, social, and governance (ESG) standards is creating a positive market outlook. Some of the other factors such as increasing healthcare spending, talent acquisition, workforce development, and Public-Private Partnerships (PPPs) are contributing to further market expansion.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.